ADVFN ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

Technology

Tern Is Now a Fertile Market for Buyers

23 Dec 2014 @ 11:26
Tern stock (LSE:TERN) is ripe for a northward movement and buyers would be wise to capitalize on that. Price broke upwards from the recent base (an equilibrium zone in the market), as it trends northward significantly. The price broke out of the upper Trendline. Before that, the bulls were making effort to push the price […]
 

Fitbug cuts deals with Amazon, Best Buy and Target

22 Dec 2014 @ 08:17
New Retail and Marketing deals agreed with Amazon, Best Buy.com and Target Fitbug Holdings Plc, the AIM quoted provider of online personal health and wellbeing services, has announced that it has agreed a number of new contracts which will positively impact its sales for both the Fitbug Orb wearable device and Kiqplan, its 12 week […]
 

Stay Away from Nanoco

17 Dec 2014 @ 20:46
Nanoco shares (LSE:NANO) are currently not attractive. This is a market in which bulls and bears may suffer if they try to open swing trading or position trading positions. This is a kind of the market in which the price always makes it difficult for most speculators to make money, because of its deceptive movement. […]
 

Ultrasis Makes Attempt to Recover Its Loses

17 Dec 2014 @ 20:37
Ultrasis stock (LSE:ULT) gapped downwards seriously in October 2014 and the considerable loss was sustained for the following few months. This month, price rose significantly, almost recovering the recent loss in the market. This may be the beginning of a long-term bullish run. What you see as a great directional movement began as a rally […]
 

Prothena receives FDA Fast Track designation

16 Dec 2014 @ 08:21
First Investigational Immunotherapy for AL Amyloidosis to Receive FDA Fast Track Designation – Follows Recent Initiation of The VITAL Amyloidosis Study, a Global Phase 3 Registrational Trial of NEOD001 for Patients with AL Amyloidosis Prothena Corporation plc (Nasdaq:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel...
 

Lending Club: The IPO You Missed

14 Dec 2014 @ 08:52
The initial offering price of Lending Club (NYSE:LC) shares was $15.00, higher than the $12.00-$14.00 range anticipated. When shares started trading for the first time on 11 December, they popped 65% before finishing the day up 56% at $23.43. Lending Club shares closed Friday at $24.69 and increased to $24.84 in after-hours trading. The Emergence […]
 

Fitbug secures £3.5m through new placing

12 Dec 2014 @ 08:50
£3.5 million Placing to Accelerate Growth, Conversion of Loan Notes and Grant of Options Fitbug Holdings Plc, the AIM quoted provider of online personal health and wellbeing services, has announced that it has successfully raised £3,510,200 (before expenses) through Hybridan LLP by way of a placing of 39,002,224 new ordinary shares of 1 pence each […]
 

Abengoa and Hyundai to collaborate on power plants?

10 Dec 2014 @ 08:40
The MoU consolidates the talks held by the companies this year and marks the starting point for the specific projects that the companies have already identified. Abengoa (MCE: ABG.B/P SM) (Nasdaq:ABGB), the international company that applies innovative technology solutions for sustainability in the energy and environment sectors, signed a memorandum of understanding in Seoul on […]
 

Northrop refresh board with new CFO

09 Dec 2014 @ 08:46
Who is the new member of the board? Northrop Grumman Corporation (NYSE:NOC) announced today that its board of directors has elected Kenneth L. Bedingfield, corporate vice president and chief financial officer, effective after the company files its 2014 annual report. Bedingfield will succeed James F. Palmer, who has announced his intention to retire in 2015. […]
 

Novadaq secures fresh patent for SPY technology

09 Dec 2014 @ 08:43
Protection in the U.S. Novadaq Technologies Inc. (Nasdaq:NVDQ) (TSX:NDQ), a developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced the recent grant of United States Patent No. 8,892,190 entitled “Method and Apparatus for Performing Intra-Operative Angiography.” NOVADAQ’s most recent U.S...
 
 
Do you want to write for our Newspaper? Get in touch: newspaper@advfn.com